Post Hoc Analysis of Nascent Geographic Atrophy Progression in the GATHER1 Trial Anat Loewenstein (Israel)
Brolucizumab for Treatment of Diabetic Macular Edema (DME): 100-Week Results from the KESTREL and KITE Studies Andrew Chang (Australia)
Personalised Treatment Interval (PTI) Dosing Dynamics in the Phase 3 YOSEMITE/RHINE Trials of Faricimab in Diabetic Macular Edema TBA
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Results From the Phase 3 TENAYA and LUCERNE Trials De-Kuang Hwang (Tajikistan)
VOYAGER: An Innovative Real-world Study of the Port Delivery System With Ranibizumab and Faricimab in Patients With nAMD and DME Adrian Koh (Singapore)
Real-World Efficacy and Safety of the Ranibizumab Port-Delivery System in Neovascular AMD: The SUMMIT Study Arshad M. Khanani (United States)
Nanopore Targeted Sequencing to Identify Pathogenic Microorganisms in Patients with Postoperative Endophthalmitis TBA
Vascular Endothelial Growth Factor (VEGF) Levels in Serum and Vitreous in Different Stages of Diabetic Retinopathy Suklengmung Buragohain (India)
Clinical study on the treatment of RRD by external scleral jacking with foldable capsular vitreous body Fangfang Fan (People's Republic of China)
Key Clinical Pearls for Evaluating Surgical Candidates, and Patient Preference, for the Port Delivery System With Ranibizumab Adrian Koh (Singapore)
Long-term Follow-up of Primary Silicone Oil Tamponade for Retinal Detachment Secondary to Macular Hole in Highly Myopic Eyes Mengyang Li (People's Republic of China)
